Failure to meet quality requirements for the batch regarding microbiological purity, which poses a potential risk to patients’ health or life and was the basis for granting the decision immediate enforceability. Potential effects: infection, complications, lack of treatment safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from this batch; check the batch number on the packaging and, if you have it, return the medicine to the pharmacy; in case of doubts, contact a doctor.
The Chief Pharmaceutical Inspector withdrew batch A981119 of Megalia from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related